Want to see IN:KIMS full AI Analyst Report?
KIMS Stock Chart & Stats
₹653.00
₹11.55(1.78%)
At close: 4:00 PM EST
₹653.00
₹11.55(1.78%)
Day’s Range― - ―
52-Week Range₹575.55 - ₹856.20
Previous CloseN/A
Volume1.26M
Average Volume (3M)23.04K
Market Cap
₹357.32B
Enterprise Value₹360.45B
Total Cash (Recent Filing)₹1.74B
Total Debt (Recent Filing)₹31.87B
Price to Earnings (P/E)139.2
Beta0.76
Next Earnings
Aug 12, 2026EPS Estimate
1.97Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)8.39
Shares Outstanding420,006,470
10 Day Avg. Volume26,167
30 Day Avg. Volume23,042
Financial Highlights & Ratios
PEG Ratio-2.77
Price to Book (P/B)11.07
Price to Sales (P/S)6.37
P/FCF Ratio-22.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)11
Revenue Forecast (FY)₹51.22B
Bulls Say, Bears Say
Bulls Say
Sustained Revenue GrowthConsistent multi-year top-line expansion (≈3x over 2021–2026 and mid‑teens growth in 2026) implies durable demand for hospital services and successful market penetration. This supports scale economics, investment payback potential, and longer-term revenue visibility across facilities.
Comprehensive Hospital NetworkA multi‑specialty tertiary/quaternary network gives structural advantages: diversified case mix, higher‑acuity procedures with better realizations, cross‑referral synergies and resilience to single‑market shocks. That breadth supports sustained patient volumes and service mix optimization.
Scale And Asset GrowthReported solid asset growth indicates ongoing capacity expansion and investment in facilities and equipment. Scale expansion can raise long‑term revenue ceilings, enhance bargaining with payers and clinicians, and improve fixed‑cost absorption once new capacity matures.
Bears Say
Rising LeverageA near‑tripling of leverage in two years materially raises financial risk and reduces flexibility. Higher debt magnifies downside in slower demand periods, increases interest burden, and constrains strategic options like M&A or capex without refinancing or equity raises.
Negative Free Cash FlowPersistent deeply negative free cash flow indicates cash consumed by capex and working capital. Over time this elevates funding risk, forces continued external financing, and delays conversion of accounting profits into shareholder cash returns absent improvement in operating cash conversion.
Margin CompressionMaterial deterioration in gross and net margins signals either rising costs, lower pricing/realizations, or adverse case mix. If structural, margin compression erodes returns on new capacity and makes highly leveraged expansion riskier unless operational efficiencies or pricing power are restored.
Krishna Institute of Medical Sciences Limited News
KIMS FAQ
What was Krishna Institute of Medical Sciences Limited’s price range in the past 12 months?
Krishna Institute of Medical Sciences Limited lowest stock price was ₹575.55 and its highest was ₹856.20 in the past 12 months.
What is Krishna Institute of Medical Sciences Limited’s market cap?
Krishna Institute of Medical Sciences Limited’s market cap is ₹357.32B.
When is Krishna Institute of Medical Sciences Limited’s upcoming earnings report date?
Krishna Institute of Medical Sciences Limited’s upcoming earnings report date is Aug 12, 2026 which is in 37 days.
How were Krishna Institute of Medical Sciences Limited’s earnings last quarter?
Krishna Institute of Medical Sciences Limited released its earnings results on May 15, 2026. The company reported ₹1.215 earnings per share for the quarter, missing the consensus estimate of ₹1.528 by -₹0.313.
Is Krishna Institute of Medical Sciences Limited overvalued?
According to Wall Street analysts Krishna Institute of Medical Sciences Limited’s price is currently Overvalued.
Does Krishna Institute of Medical Sciences Limited pay dividends?
Krishna Institute of Medical Sciences Limited does not currently pay dividends.
What is Krishna Institute of Medical Sciences Limited’s EPS estimate?
Krishna Institute of Medical Sciences Limited’s EPS estimate is 1.97.
How many shares outstanding does Krishna Institute of Medical Sciences Limited have?
Krishna Institute of Medical Sciences Limited has 420,006,470 shares outstanding.
What happened to Krishna Institute of Medical Sciences Limited’s price movement after its last earnings report?
Krishna Institute of Medical Sciences Limited reported an EPS of ₹1.215 in its last earnings report, missing expectations of ₹1.528. Following the earnings report the stock price went down -1.767%.
Which hedge fund is a major shareholder of Krishna Institute of Medical Sciences Limited?
Currently, no hedge funds are holding shares in IN:KIMS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited, known by its brand KIMS Hospitals across India, delivers a broad spectrum of medical and healthcare services. The institution boasts a comprehensive array of specialized fields, including cardiology, dentistry, neurology, oncology, orthopedics, nephrology, reproductive medicine, and robotic surgeries. Additionally, it offers expertise in gastroenterology, hepatology, heart and lung transplantation, general organ transplantation, maternal and pediatric care. Other key areas of focus include emergency and accident services, biochemistry, anesthesiology, bariatric surgery, andrology and infertility treatments, arthroscopy, Alzheimer's care, and dedicated bone and joint centers. Founded in 1973, the company is headquartered in Secunderabad, India.
Technical Analysis
Apollo Hospitals Enterprise Limited
―
Fortis Healthcare Ltd.
―
Max Healthcare Institute Ltd
―
Global Health Limited
―
Narayana Hrudayalaya Ltd.
―